Featured Research

from universities, journals, and other organizations

Pox To Pimples; Study Says Acne-like Outbreak Not Vaccinia

Date:
June 26, 2003
Source:
Vanderbilt University Medical Center
Summary:
The national smallpox vaccine program proved last year to be a bumpy road; it was also especially spotty for about 10 percent Vanderbilt's vaccinated volunteers who broke out in a curious acne-like rash.

The national smallpox vaccine program proved last year to be a bumpy road; it was also especially spotty for about 10 percent Vanderbilt's vaccinated volunteers who broke out in a curious acne-like rash.

"Several of the volunteers said their acne worsened, and we weren't sure it was the vaccine," said Dr. Tom Talbot, an Infectious Diseases fellow and co-investigator in Vanderbilt's smallpox vaccine clinical trials. (The national trials also were coordinated here.)

He set the claims aside -- this type of reaction hadn't been documented in previous vaccinations -- but the investigative side of his public health brain kept it simmering.

"Then in late October (2002, during the clinical trial), we saw two volunteers with generalized rashes on their backs and legs and we became more attuned to a possible association with the vaccine," Talbot said. "The second light bulb to go off was in a news story in which one volunteer noted new "acne" on his back after vaccination. He said he 'felt like a teen-ager again'."

That's all the evidence Talbot needed to start his own sleuthing. He documented the outbreaks and biopsied pustules on seven patients, and compiled the data into a rash study that ran in the June 25 issue of the Journal of the American Medical Association

From October to the first of December last year, his study reports, 148 volunteers participated in the most recent of Vanderbilt's smallpox vaccine trial. All were between 18 and 32 years old, had never received the vaccine and passed a health battery. Talbot and Dr. Kathryn Edwards, professor of Pediatrics and vice chair for Pediatric Research, were testing the efficacy of the Aventis Pasteur smallpox vaccine at full strength and in dilutions of one-to-five and one-to-10.

Between eight and 10 days post-vaccination, the time of maximal viral replication, four people had a generalized rash of pustules on their arms, legs, face, back and trunk; 11 had a similar, but more focal, reaction.

Historical accounts of smallpox vaccine side effects listed "non-descript rashes or general vaccinia," a spreading of the virus throughout the body, a sometimes fatal side effect, Talbot said. But, he added, "they were never well described."

Samples of the lesions seen at Vanderbilt tested negative for the virus, ruling out vaccinia and possibly establishing a new, less serious, reaction to the vaccine: folliculitis, benign eruptions like pimples.

"We wanted to see if this eruption was common in adults after vaccination, and if it could be mistaken for general vaccinia," Talbot said. The paper, he said, was an effort to lessen anxiety and provide some clarity for physicians who might see the rash on patients and confuse the less serious reaction with a fatal one.

"Tom conducted a meticulous study of reactions after vaccination," said Edwards, a co-author on the study. "Many investigators saw small blisters after vaccination and believed that they represented disseminated vaccinia. However, Tom discovered that much to the contrary, the lesions were a folliculitis and did not represent infectious virus at all. His findings are reassuring for our upcoming studies and for the military population who continues to be immunized."

The reasons for folliculitis, Talbot suggests, might lie in the differences between the adults in the smallpox vaccine trial population and the children who routinely received the vaccine until 1972.

"Children don't have as many hair follicles as adults, which may explain the high incidence in the study population of adults," Talbot said. He and his colleagues propose that the eruption may be related to the vigorous immune response seen after vaccination. Reassuringly, volunteers had minimal to no symptoms related to the eruption, which was also short-lived and resolved without scarring.

Three other smallpox vaccine studies, in civilian and military populations, ran in the same JAMA issue that carried Talbot's. An editorial by Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said Talbot's study "illustrates the value of reevaluating seemingly established phenomena when new (diagnostic and technological) tools become available."

"If these cases had occurred 40 years ago, when cultures were not routinely performed on lesions occurring after vaccination, these individuals might have been diagnosed as having generalized vaccinia," Fauci and co-author Dr. Mary E. Wright, also of the NIAID, wrote.


Story Source:

The above story is based on materials provided by Vanderbilt University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Vanderbilt University Medical Center. "Pox To Pimples; Study Says Acne-like Outbreak Not Vaccinia." ScienceDaily. ScienceDaily, 26 June 2003. <www.sciencedaily.com/releases/2003/06/030626074234.htm>.
Vanderbilt University Medical Center. (2003, June 26). Pox To Pimples; Study Says Acne-like Outbreak Not Vaccinia. ScienceDaily. Retrieved September 17, 2014 from www.sciencedaily.com/releases/2003/06/030626074234.htm
Vanderbilt University Medical Center. "Pox To Pimples; Study Says Acne-like Outbreak Not Vaccinia." ScienceDaily. www.sciencedaily.com/releases/2003/06/030626074234.htm (accessed September 17, 2014).

Share This



More Health & Medicine News

Wednesday, September 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins